HUNTINGTON, W.Va. (WSAZ) - A free symposium this month is highlighting resources for patients with Movement Disorders like Parkinson’s Disease. Dr. Matthew Burton and Dr. Heather Pinckard-Dover from ...

Introduction Previous trauma and adverse life experiences have been hypothesised to be aetiological factors for functional neurological disorder (FND) leading to the hypothesis of a ‘trauma-subtype’ ...

Southwell Outpatient Therapy Services in Tifton has recently added neurologic physical therapy (PT) to its array of rehabilitative services.

For more about dementia, please read studies about Scientists find a drug related to Viagra may help treat vascular dementia ...

SAN DIEGO, October 02, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced one late-breaker oral platform presentation and two poster presentations to be presented at the ...

· Amlenetug has previously received Orphan Drug Designation (ODD) from the US FDA and the EMA in Europe, in addition to SAKIGAKE designation in Japan Valby, Denmark, 2 October 2025 – H. Lundbeck A/S ...

Health monitoring platform Empatica announced it acquired PKG Health, a company offering movement disorder algorithms and digital endpoints for Parkinson’s disease. Empatica offers AI-enabled ...

Is your neck stiff and tight? Are your wrists aching after hours of typing? Do your back and shoulders hurt from lifting and ...

In his epic new history of the Western Hemisphere, America, América, Greg Grandin recounts how the great Cuban revolutionary ...

ARV-102 is an oral, brain-penetrant investigational PROTAC designed to degrade LRRK2, which is a large, multidomain scaffolding kinase. Increased activity, scaffolding, and expression of LRRK2 have ...

Details of the Phase 3 MASCOT trial investigating amlenetug for the treatment of patients with Multiple System Atrophy (MSA) will be presented at the International Congress of Parkinson's Disease and ...